My assignments for Rheumatology Network
include reporting on recent scientific studies about rheumatoid
arthritis and other related diseases. For the month of October my articles focus on coverage of the American College of Rheumatology Annual Meeting that took place in Chicago, Illinois.
Although these articles are
intended primarily for a physician audience, I know patients are also interested in
scientific advances. If you ever have additional questions, please don't hesitate to let
me know!
New recommendations cover pre-conception assessment, pregnancy-compatible medications, breastfeeding, and contraception for rheumatology patients.
New guidelines have been drafted for the treatment of JIA, specifically addressing therapeutic approaches for non-systemic polyarthritis, sacroiilitis, and enthesitis.
The pros and cons of HCQ dosing guidelines to limit potential eye toxicity were explored at this year's ACR/ARHP Annual Meeting.
Findings from the first study to incorporate a meta-analysis on TNFi dose adjustment in an axSpA population.
Seropositivity was strongly associated with ILD risk in this large prospective cohort study.
British researchers quantified the burden of continuing weight gain on the risk of PsA.
Be alert for the development of uveitis in older patients with gout, especially those who have multiple comorbidities.
No comments:
Post a Comment
Thanks so much for leaving a comment! I really appreciate the support and I love hearing from all of you! My blog is a forum for finding support and discussing life with RA so I will try to publish and respond to comments as soon as I can!
Unfortunately, I have been getting a lot of nonsense comments with spam links in them recently. This means that I have had to turn the comment moderation on. My blog is not a place for advertizing, so if your comment contains a spam link it will not be published. Please respect my blog.
Thank you.